Equillium (EQ) Free Cash Flow (2018 - 2026)
Equillium (EQ) reported Free Cash Flow of -$4.3 million for Q1 2026, up 47.34% year-over-year from -$2.9 million in Q1 2025, and down 35.47% quarter-over-quarter from -$3.2 million in Q4 2025.
Equillium (EQ) Free Cash Flow (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Free Cash Flow data on file, last reported at -$4.3 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$4.3 million, up 47.34% year-over-year; the trailing twelve-month figure through Mar 2026 was -$18.9 million (down 2.71% YoY), and the FY2025 annual result was -$22.8 million, down 19.27% from the prior year.
- Free Cash Flow retreated to -$4.3 million in Q1 2026 per EQ's latest filing, from -$3.2 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $27.4 million in Q4 2022 and troughed at -$12.8 million in Q3 2022.
- A 5-year average of -$4.5 million and a median of -$6.2 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow surged 372.04% in 2022, then plunged 525.56% in 2025.
- A 5-year view of Free Cash Flow shows it stood at $27.4 million in 2022, then sank by 120.76% to -$5.7 million in 2023, then surged by 42.04% to -$3.3 million in 2024, then increased by 3.81% to -$3.2 million in 2025, then sank by 35.47% to -$4.3 million in 2026.
- Business Quant data shows EQ's Free Cash Flow at -$4.3 million in Q1 2026, -$3.2 million in Q4 2025, and -$8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | -4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.30 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Dec 31, 2025 | -3.18 Mn |
| Dec 31, 2025 | -3.18 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -3.01 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Mar 31, 2025 | -8.17 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Dec 31, 2024 | -3.30 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Sep 30, 2024 | -7.66 Mn |
| Jun 30, 2024 | 708,000.00 |
| Jun 30, 2024 | 708,000.00 |
| Mar 31, 2024 | -8.86 Mn |
| Mar 31, 2024 | -8.86 Mn |
| Dec 31, 2023 | -5.70 Mn |
| Dec 31, 2023 | -5.70 Mn |